Lesley Lokko

Lesley Naa Norle Lokko is a Ghanaian-Scottish architect, academic, and novelist.[1] She says: "I live almost simultaneously in Johannesburg, London, Accra and Edinburgh."[2]

Lesley Lokko
BornLesley Naa Norle Lokko
Dundee, Scotland
OccupationArchitect, academic, novelist
NationalityGhanaian-Scottish
Alma materUniversity College London[1]
Website
www.lesleylokko.com

Early life and education

Lesley Lokko was born in Dundee, the daughter of a Ghanaian surgeon and a Scottish Jewish mother, and grew up in Ghana and Scotland.[3][4] At the age of 17 she went to a private boarding school in England.[5] She began studying Hebrew and Arabic at Oxford University, but left the programme to go to the United States.[4] She graduated from the Bartlett School of Architecture, University College London, with a BSc(Arch) in 1992, and an March in 1995, and went on to earn a PhD in Architecture from the University of London in 2007.[6]

Career

Much of Lokko's writing contains themes about cultural and racial identity.[7] She regularly lectures in South Africa,[4] and has also taught in the United Kingdom and the United States.[1] She also writes regularly for The Architectural Review.[8] In 2015 she became Head of the newly established Graduate School and Associate Professor of Architecture at the University of Johannesburg.[9][10][11] In June 2019 she was named as dean of the Bernard and Anne Spitzer School of Architecture at the City College of New York.[11]

Selected published works

  • 2000: White Papers, Black Marks: Race, Culture, Architecture[1]
  • 2004: Sundowners[1]
  • 2005: Saffron Skies[1]
  • 2008: Bitter Chocolate[1]
  • 2009: Rich Girl, Poor Girl[12]
  • 2010: One Secret Summer[13]
  • 2011: A Private Affair[1]
  • 2012: An Absolute Deception[1]
  • 2014: Little White Lies[1]

As editor

  • 2000: White Papers, Black Marks: Architecture, Race, Culture[6]
gollark: People do *not* seem very excited about... fluvoxamine or whatever... despite that actually having efficacy.
gollark: Anything for COVID-19, I mean.
gollark: Well, the interesting question is whether it does anything. Not safety.
gollark: There have already been big trials for ivermectin for COVID-19. Just negative ones.
gollark: Because it somehow became a political issue, I think people mostly just end up believing that ivermectin is or isn't good based on their group's politics.

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.